BK-1361 is a peptidomimetic ADAM8 inhibitor, affecting ADAM8 function, and leading to less ERK1/2 and MMP activation, with an anti-invasion effect in pancreatic cancer [65]. This evidence concerns the gene ADAM8 and familial pancreatic carcinoma.